Therefore, our study aimed to evaluate the effects of elevated NT-proBNP on the risk of hyperuricemia and long-term mortality among US adults without prevalent cardiovascular disease, and performed further subgroup analyses to determine the risk estimates for different populations. This evidence concerns the gene NPPB and hyperuricemia.